The HIV market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs, vaccines, and other treatments to prevent and manage the virus. Research is also conducted to understand the underlying mechanisms of HIV and its effects on the immune system. Additionally, the market includes the development of diagnostics and tests to detect the virus and monitor its progression. The HIV market is highly competitive, with many companies involved in the development of treatments and therapies. These include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare. Other companies involved in the market include AbbVie, Janssen, and Pfizer. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
